OOIR: Observatory of International Research

Papers

(The median citation count of Retrovirology is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)

Article	Citations
The key amino acid sites 199–205, 269, 319, 321 and 324 of ALV-K env contribute to the weaker replication capacity of ALV-K than ALV-A	44
A complex network of transcription factors and epigenetic regulators involved in bovine leukemia virus transcriptional regulation	38
Transmitted/founder SHIV.D replicates in the brain, causes neuropathogenesis, and persists on combination antiretroviral therapy in rhesus macaques	30
The KT Jeang Retrovirology prize 2022: Florence Margottin-Goguet	27
HIVIntact: a python-based tool for HIV-1 genome intactness inference	27
Subtype-specific differences in Gag-protease replication capacity of HIV-1 isolates from East and West Africa	22
HUSH-mediated HIV silencing is independent of TASOR phosphorylation on threonine 819	22
Characterisation of a highly potent and near pan-neutralising anti-HIV monoclonal antibody expressed in tobacco plants	21
An endogenous lentivirus in the germline of a rodent	19
Comprehensive identification and characterization of the HERV-K (HML-9) group in the human genome	17
P-selectin glycoprotein ligand-1 (PSGL-1/CD162) is incorporated into clinical HIV-1 isolates and can mediate virus capture and subsequent transfer to permissive cells	15
No evidence of bovine leukemia virus proviral DNA and antibodies in human specimens from Japan	14
A novel class III endogenous retrovirus with a class I envelope gene in African frogs with an intact genome and developmentally regulated transcripts in Xenopus tropicalis	14
Shared and unique patterns of autonomous human endogenous retrovirus loci transcriptomes in CD14 + monocytes from individuals with physical trauma or infection with COVID-19	12
YTHDC1 regulates distinct post-integration steps of HIV-1 replication and is important for viral infectivity	11
Retroviral PBS-segment sequence and structure: Orchestrating early and late replication events	11
Opposing roles of CLK SR kinases in controlling HIV-1 gene expression and latency	10
Interview with a Retrovirologist: Sebla B. Kutluay in conversation with Carol Carter	9
Bovine leukemia virus (BLV) and risk of breast cancer; a systematic review and meta-analysis	9
Heterologous avian system for quantitative analysis of Syncytin-1 interaction with ASCT2 receptor	9
Vpx enhances innate immune responses independently of SAMHD1 during HIV-1 infection	9
Bone marrow stromal antigen 2 (BST-2) genetic variants influence expression levels and disease outcome in HIV-1 chronically infected patients	9
Conformational antigenic heterogeneity as a cause of the persistent fraction in HIV-1 neutralization	8
HERVK-mediated regulation of neighboring genes: implications for breast cancer prognosis	8
Arginyl-tRNA-protein transferase 1 contributes to governing optimal stability of the human immunodeficiency virus type 1 core	8

Correction to: Human T-cell leukaemia virus type 1 associated pulmonary disease: clinical and pathological features of an under-recognised complication of HTLV-1 infection	8
Reduced CCR5 expression among Uganda HIV controllers	7
Residues T48 and A49 in HIV-1 NL4-3 Nef are responsible for the counteraction of autophagy initiation, which prevents the ubiquitin-dependent degradation of Gag through autophagosomes	7
Co-receptor signaling in the pathogenesis of neuroHIV	7
Advancing our understanding of HIV co-infections and neurological disease using the humanized mouse	7
Derivation and characterization of an HIV-1 mutant that rescues IP6 binding deficiency	6
Cocaine augments neuro-inflammation via modulating extracellular vesicle release in HIV-1 infected immune cells	6
HIV-1 integrase binding to genomic RNA 5′-UTR induces local structural changes in vitro and in virio	6
CRISPR/Cas9 genome editing to create nonhuman primate models for studying stem cell therapies for HIV infection	6
HIV infection of non-classical cells in the brain	5
A gut check: understanding the interplay of the gastrointestinal microbiome and the developing immune system towards the goal of pediatric HIV remission	5
High level of genomic divergence in orf-I p12 and hbz genes of HTLV-1 subtype-C in Central Australia	5
Two lymphoid cell lines potently silence unintegrated HIV-1 DNAs	5
Editing out HIV: application of gene editing technology to achieve functional cure	5
The HIV-1 capsid and reverse transcription	5
Memoriam for Renaud Mahieux	5
Altered Env conformational dynamics as a mechanism of resistance to peptide-triazole HIV-1 inactivators	4
Immunoescape of HIV-1 in Env-EL9 CD8 + T cell response restricted by HLA-B*14:02 in a Non progressor who lost twenty-seven years of HIV-1 control	4
In situ analysis of neuronal injury and neuroinflammation during HIV-1 infection	3
Replication-competent HIV-1 in human alveolar macrophages and monocytes despite nucleotide pools with elevated dUTP	3
HIV-1 capsid exploitation of the host microtubule cytoskeleton during early infection	3
Integration of SARS-CoV-2 RNA in infected human cells by retrotransposons: an unlikely hypothesis and old viral relationships	3
Interview with a Retrovirologist: Wibke Bayer in conversation with Hung Fan	3
Repression of HIV-1 reactivation mediated by CRISPR/dCas9-KRAB in lymphoid and myeloid cell models	3
A detailed analysis of F-MuLV- and SFFV-infected cells in Friend virus-infected mice reveals the contribution of both F-MuLV- and SFFV-infected cells to the interleukin-10 host response	3
Endogenous feline leukemia virus long terminal repeat integration site diversity is highly variable in related and unrelated domestic cats	3
HIV-2/SIV Vpx antagonises NF-κB activation by targeting p65	3
Correction to: A novel Betaretrovirus discovered in cattle with neurological disease and encephalitis	3
HIV-1 capsid variability: viral exploitation and evasion of capsid-binding molecules	3
MicroRNAs and long non-coding RNAs during transcriptional regulation and latency of HIV and HTLV	3
Diverse antiviral IgG effector activities are predicted by unique biophysical antibody features	3
A clinical review of HIV integrase strand transfer inhibitors (INSTIs) for the prevention and treatment of HIV-1 infection	3
Impact of HIV-1 CRF55_01B infection on the evolution of CD4 count and plasma HIV RNA load in men who have sex with men prior to antiretroviral therapy	3
Functional analysis of a monoclonal antibody reactive against the C1C2 of Env obtained from a patient infected with HIV-1 CRF02_AG	3